rs41557217

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_000179.3(MSH6):​c.663A>C​(p.Glu221Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000748 in 1,612,862 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E221K) has been classified as Uncertain significance.

Frequency

Genomes: š‘“ 0.00063 ( 1 hom., cov: 32)
Exomes š‘“: 0.00076 ( 0 hom. )

Consequence

MSH6
NM_000179.3 missense

Scores

2
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:20O:1

Conservation

PhyloP100: -0.266

Publications

33 publications found
Variant links:
Genes affected
MSH6 (HGNC:7329): (mutS homolog 6) This gene encodes a member of the DNA mismatch repair MutS family. In E. coli, the MutS protein helps in the recognition of mismatched nucleotides prior to their repair. A highly conserved region of approximately 150 aa, called the Walker-A adenine nucleotide binding motif, exists in MutS homologs. The encoded protein heterodimerizes with MSH2 to form a mismatch recognition complex that functions as a bidirectional molecular switch that exchanges ADP and ATP as DNA mismatches are bound and dissociated. Mutations in this gene may be associated with hereditary nonpolyposis colon cancer, colorectal cancer, and endometrial cancer. Transcripts variants encoding different isoforms have been described. [provided by RefSeq, Jul 2013]
FBXO11 (HGNC:13590): (F-box protein 11) This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbxs class. It can function as an arginine methyltransferase that symmetrically dimethylates arginine residues, and it acts as an adaptor protein to mediate the neddylation of p53, which leads to the suppression of p53 function. This gene is known to be down-regulated in melanocytes from patients with vitiligo, a skin disorder that results in depigmentation. Polymorphisms in this gene are associated with chronic otitis media with effusion and recurrent otitis media (COME/ROM), a hearing loss disorder, and the knockout of the homologous mouse gene results in the deaf mouse mutant Jeff (Jf), a single gene model of otitis media. Alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jun 2010]
FBXO11 Gene-Disease associations (from GenCC):
  • intellectual developmental disorder with dysmorphic facies and behavioral abnormalities
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.031133354).
BP6
Variant 2-47798646-A-C is Benign according to our data. Variant chr2-47798646-A-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 89552.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00063 (96/152354) while in subpopulation AMR AF = 0.000915 (14/15294). AF 95% confidence interval is 0.000716. There are 1 homozygotes in GnomAd4. There are 53 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000179.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSH6
NM_000179.3
MANE Select
c.663A>Cp.Glu221Asp
missense
Exon 4 of 10NP_000170.1P52701-1
MSH6
NM_001406795.1
c.759A>Cp.Glu253Asp
missense
Exon 5 of 11NP_001393724.1
MSH6
NM_001406813.1
c.669A>Cp.Glu223Asp
missense
Exon 4 of 10NP_001393742.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSH6
ENST00000234420.11
TSL:1 MANE Select
c.663A>Cp.Glu221Asp
missense
Exon 4 of 10ENSP00000234420.5P52701-1
MSH6
ENST00000445503.5
TSL:1
n.*10A>C
non_coding_transcript_exon
Exon 3 of 9ENSP00000405294.1F8WAX8
MSH6
ENST00000445503.5
TSL:1
n.*10A>C
3_prime_UTR
Exon 3 of 9ENSP00000405294.1F8WAX8

Frequencies

GnomAD3 genomes
AF:
0.000631
AC:
96
AN:
152236
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000313
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000917
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000897
Gnomad OTH
AF:
0.000955
GnomAD2 exomes
AF:
0.000706
AC:
176
AN:
249320
AF XY:
0.000801
show subpopulations
Gnomad AFR exome
AF:
0.000247
Gnomad AMR exome
AF:
0.000376
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000491
Gnomad NFE exome
AF:
0.00107
Gnomad OTH exome
AF:
0.000491
GnomAD4 exome
AF:
0.000760
AC:
1110
AN:
1460508
Hom.:
0
Cov.:
34
AF XY:
0.000801
AC XY:
582
AN XY:
726568
show subpopulations
African (AFR)
AF:
0.0000597
AC:
2
AN:
33480
American (AMR)
AF:
0.000470
AC:
21
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00123
AC:
106
AN:
86248
European-Finnish (FIN)
AF:
0.0000576
AC:
3
AN:
52124
Middle Eastern (MID)
AF:
0.000696
AC:
4
AN:
5750
European-Non Finnish (NFE)
AF:
0.000846
AC:
941
AN:
1111972
Other (OTH)
AF:
0.000547
AC:
33
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
61
122
183
244
305
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000630
AC:
96
AN:
152354
Hom.:
1
Cov.:
32
AF XY:
0.000711
AC XY:
53
AN XY:
74510
show subpopulations
African (AFR)
AF:
0.000313
AC:
13
AN:
41596
American (AMR)
AF:
0.000915
AC:
14
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5190
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000897
AC:
61
AN:
68028
Other (OTH)
AF:
0.000945
AC:
2
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000739
Hom.:
1
Bravo
AF:
0.000646
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00128
AC:
11
ExAC
AF:
0.000618
AC:
75
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00131
EpiControl
AF:
0.000830

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
Hereditary cancer-predisposing syndrome (6)
-
1
5
not provided (6)
-
1
4
not specified (6)
-
2
1
Lynch syndrome 5 (3)
-
1
-
Abnormality of the ovary (1)
-
-
1
Breast and/or ovarian cancer (1)
-
-
1
Carcinoma of colon (1)
-
-
1
Hereditary cancer (1)
-
-
1
Hereditary nonpolyposis colorectal neoplasms (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.23
CADD
Benign
9.7
DANN
Uncertain
0.98
DEOGEN2
Benign
0.28
T
Eigen
Benign
-0.50
Eigen_PC
Benign
-0.50
FATHMM_MKL
Benign
0.74
D
LIST_S2
Benign
0.64
T
M_CAP
Benign
0.023
T
MetaRNN
Benign
0.031
T
MetaSVM
Benign
-0.56
T
MutationAssessor
Benign
1.6
L
PhyloP100
-0.27
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-0.87
N
REVEL
Uncertain
0.32
Sift
Benign
0.16
T
Sift4G
Benign
0.42
T
Polyphen
0.0030
B
Vest4
0.17
MutPred
0.092
Gain of relative solvent accessibility (P = 0.09)
MVP
0.84
ClinPred
0.0068
T
GERP RS
-0.72
RBP_binding_hub_radar
0.97
RBP_regulation_power_radar
3.2
Varity_R
0.032
gMVP
0.073
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41557217; hg19: chr2-48025785; COSMIC: COSV52286342; COSMIC: COSV52286342; API